Daré Bioscience, Inc. (DARE)

0.7734 0.00 (0.00%) USD  |  NASDAQ  |  Oct 09, 16:00
0.773 0.00 (0.00%) After-Hours: 20:00
More

Daré Bioscience Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for DARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
August 14, 2026 --
May 18, 2026 --
May 15, 2026 --
April 09, 2026 --
March 27, 2026 --
February 28, 2026 --
December 31, 2025 --
November 14, 2025 --
November 10, 2025 --
September 04, 2025 --
August 18, 2025 --
August 16, 2025 --
July 15, 2025 --
June 05, 2025 --
May 14, 2025 --
Date Value
April 03, 2025 --
April 01, 2025 --
December 16, 2024 --
November 15, 2024 --
August 15, 2024 --
August 14, 2024 --
August 13, 2024 --
May 16, 2024 --
May 15, 2024 --
April 30, 2024 --
April 02, 2024 --
April 01, 2024 --
January 31, 2024 --
January 29, 2024 --
January 02, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Elite Pharmaceuticals, Inc. Upgrade
Eton Pharmaceuticals, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade